Is there even a remote possibility of filing for both Ignite 1 and 2, during the last presentation, they said they ran the numbers again with IV only not pill, and were superior to Lev. They also mentioned the micro set of patients. Did you go over this scenario?
I think that is why the stock is up, if they can do a small effectiveness study, they will get approval. Safety was not mentioned in the letter. SRPT stock is down a buck on the news.